Pfizer and BioNTech have forwarded a request to the European Medicines Agency to approve the use of their jointly developed coronavirus vaccine on children 12 to 15 years old.
The post Pfizer, BioNTech Seek EU Approval to Use COVID Vaccine on Children: Report appeared first on The Washington Informer.
